| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 60.23B | 59.79B | 54.43B | 57.07B | 54.92B | 55.51B |
| Gross Profit | 28.38B | 27.25B | 26.12B | 26.88B | 26.09B | 26.37B |
| EBITDA | 4.29B | 4.25B | 3.42B | 4.42B | 3.96B | 4.11B |
| Net Income | 1.54B | 1.36B | 1.44B | 2.00B | 1.71B | 1.84B |
Balance Sheet | ||||||
| Total Assets | 36.78B | 38.19B | 37.62B | 38.73B | 39.72B | 40.85B |
| Cash, Cash Equivalents and Short-Term Investments | 6.62B | 8.59B | 8.06B | 11.03B | 12.29B | 14.29B |
| Total Debt | 6.24B | 7.22B | 7.18B | 7.23B | 8.83B | 11.30B |
| Total Liabilities | 15.12B | 15.79B | 14.89B | 15.53B | 17.58B | 19.49B |
| Stockholders Equity | 21.65B | 22.39B | 22.71B | 23.20B | 22.06B | 21.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.80B | -121.00M | 1.55B | 2.68B | 6.25B |
| Operating Cash Flow | 0.00 | 4.15B | 166.00M | 1.74B | 2.88B | 6.51B |
| Investing Cash Flow | 0.00 | -575.00M | -1.27B | -393.00M | -1.14B | -1.50B |
| Financing Cash Flow | 0.00 | -3.07B | -1.91B | -2.56B | -3.74B | 54.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥26.06B | 11.92 | ― | 2.37% | 1.26% | 0.21% | |
73 Outperform | ¥21.32B | 8.25 | ― | 2.97% | -0.83% | 30.11% | |
73 Outperform | ¥26.67B | 9.70 | ― | 3.44% | -3.65% | -5.87% | |
65 Neutral | ¥21.18B | -39.49 | ― | 3.59% | 4.27% | 50.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥23.18B | 10.65 | ― | 4.18% | -2.47% | -32.07% | |
49 Neutral | ¥59.27B | -34.32 | ― | ― | -9.88% | -12.16% |